Solara Active Pharma Sciences Limited — Board Meeting, 21-02-2025: Outcome of Board Meeting

The Board meeting resulted in several key outcomes. Solara Active Pharma Sciences has decided to close its wholly owned subsidiary in Brazil due to lack of operations. Additionally, the Board approved the grant of 3,50,000 employee stock options under the Solara ESOP 2024, priced at Rs. 375 each. Changes in leadership were also made: Mr. Sandeep Rao has been appointed as Managing Director and CEO, while Mr. Sarat Kumar takes on the role of Chief Financial Officer. Mr. Poorvank Purohit and Mr. Arun Kumar Baskaran resigned from their respective MD & CEO and CFO positions.